CD4 and AIDS: After adjustment for prior ARV exposure, comorbidities, AIDS-defining events, sex, age, and health plan type, patients with CD4 cell counts <100 cells/μL had significantly higher (92% increased; p<0.001) costs per person-month as compared to those with CD4 cell counts >350 cells/μL (Table 2).